Masouridi-Levrat, S., Olavarria, E., Iacobelli, S., Aljurf, M., Morozova, E., Niittyvuopio, R., et al. (2022). Outcomes and toxicity of allogeneic HCT in CML patients previously treated with second generation TKIs: a prospective non-interventional study from the Chronic Malignancy Working Party of EBMT. BONE MARROW TRANSPLANTATION, 57(1), 23-30.

Outcomes and toxicity of allogeneic HCT in CML patients previously treated with second generation TKIs: a prospective non-interventional study from the Chronic Malignancy Working Party of EBMT

Iacobelli S;
2022-01-01

2022
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/01 - STATISTICA MEDICA
English
Con Impact Factor ISI
Masouridi-Levrat, S., Olavarria, E., Iacobelli, S., Aljurf, M., Morozova, E., Niittyvuopio, R., et al. (2022). Outcomes and toxicity of allogeneic HCT in CML patients previously treated with second generation TKIs: a prospective non-interventional study from the Chronic Malignancy Working Party of EBMT. BONE MARROW TRANSPLANTATION, 57(1), 23-30.
Masouridi-Levrat, S; Olavarria, E; Iacobelli, S; Aljurf, M; Morozova, E; Niittyvuopio, R; Sengeloev, H; Remenyi, P; Helbig, G; Browne, P; Ganser, A; N...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Masouridi_TKI-NIS_BMT_2021.pdf

accesso aperto

Licenza: Creative commons
Dimensione 1.1 MB
Formato Adobe PDF
1.1 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/302940
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 7
social impact